Physician profile
James S Cox
NPI 1083654008
$1,815.54
in general payments reported to CMS, 2019-2025
18 companies · $232 in 2025
The $232 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $58.28 · 2021: $219 · 2022: $307 · 2023: $248 · 2024: $299 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $270.18 | 2021-2024 | Jornay Pm |
| Pfizer INC. | $260.73 | 2019-2025 | |
| Kaleo, INC. | $236.08 | 2019-2023 | Auvi-Q |
| Takeda Pharmaceuticals U.S.A., INC. | $176.87 | 2019-2022 | |
| Neos Therapeutics, LP | $134.62 | 2019-2024 | Adzenys Xr-Odt |
| Sanofi Pasteur INC. | $103.13 | 2019-2025 | |
| Cranial Technologies, INC | $103.07 | 2020-2025 | Doc Band |
| Biofire Diagnostics, LLC | $99.04 | 2019 | |
| Merck Sharp & Dohme LLC | $93.97 | 2022-2025 | Gardasil 9, Vaxelis, Gardasil |
| Corium, LLC | $77.40 | 2021-2022 | |
| Glaxosmithkline, LLC. | $66.01 | 2019-2024 | Bexsero |
| Sanofi-Aventis U.S. LLC | $43.01 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $41.41 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $35.50 | 2021-2024 | Qelbree |
| Tris Pharma INC | $29.77 | 2021-2023 | Dyanavel Xr |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $16.44 | 2023 | |
| Seqirus USA INC | $15.83 | 2022 | |
| Adlon Therapeutics L.P. | $12.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.